Follow us for updates
© 2022 reportr.world
Read the Story →

Mercury Drug Says Ivermectin Available Soon, Waiting for Final Clearance

Prescription is required.
by Clara Rosales
May 11, 2021
Photo/s: Shutterstock
Shares

Mercury Drug said Tuesday it would soon sell Ivermectin tablets as a prescription drug as soon as authorities clear the final product for commercial sale.

The country's largest drugstore chain cited the Food and Drug Administration's recent approval of Ivermectin as an anti-nematodal or dewormer. The drug, which some politicians advocate for COVID treatment, is used to treat lice and worms in humans and animals.

"We are awaiting for the final product to be available for commercial sale. Rest assured Ivermectin will soon be available at Mercury Drug stores nationwide," the advisory said.

Continue reading below ↓

Research has yet to back claims that Ivermectin is effective against COVID-19 and health officials have warned the public against using it  to treat the viral disease.

Last April, the FDA gave six hospitals compassionate use permits to administer the drug to COVID-positive patients.

MORE ON IVERMECTIN:

When is Ivermectin Use Considered Legal, Illegal?

DOH, FDA Say Ivermectin Not Recommended for COVID Treatment

'To Each His Own': Sotto Says Filipinos Should Be Free to Take Ivermectin

Continue reading below ↓
Recommended Videos
Latest Headlines
Read Next
Recent News
Appointment announced a day before Marcos' inauguration.
More time for K-drama, books, and mornings without alarms.
With the reopening of several local destinations, this app has never been more timely.
You can participate in person and virtually.
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to reportr.world newsletter, you agree to our Terms of Service and Privacy Policy.